(Q53744742)
Statements
Gastrointestinal tolerability of the selective cyclooxygenase-2 (COX-2) inhibitor rofecoxib compared with nonselective COX-1 and COX-2 inhibitors in osteoarthritis. (English)
Watson DJ
Harper SE
Zhao PL
Quan H
Bolognese JA
Simon TJ
1 October 2000
160
19
2998-3003